TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 17, No. 11 June 1, 2011
(The next issue will be on June 15, 2011)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1VIYzi36diIQjGMaN3yDCRU/
Abe R, Yamashita N, Rochier A, Nixon A, Madri JA, Sumpio BE (2011) Varying Effects of Hemodynamic Forces on Tissue Factor RNA Expression in Human Endothelial Cells. J Surg Res.
http://www.ncbi.nlm.nih.gov/pubmed/21592524
Banfi C, Brioschi M, Lento S, Pirillo A, Galli S, Cosentino S, . . . Mussoni L (2011) Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21605334
Ben-Hadj-Khalifa S, Hezard N, Almawi WY, Remy MG, Florent B, Mahjoub T, Nguyen P (2011) Differential coagulation inhibitory effect of fondaparinux, enoxaparin and unfractionated heparin in cell models of thrombin generation. Blood Coagul Fibrinolysis.
http://www.ncbi.nlm.nih.gov/pubmed/21577096
Butros L, Boayue K, Mathew P (2011) Current difficulties and recent advances in bypass therapy for the management of hemophilia with inhibitors: a new and practical formulation of recombinant factor VIIa. Drug Des Devel Ther 5:275-282.
http://www.ncbi.nlm.nih.gov/pubmed/21625417
Chapman AJ, Blount AL, Davis AT, Hooker RL (2011) Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery. Eur J Cardiothorac Surg.
http://www.ncbi.nlm.nih.gov/pubmed/21601468
Darlington DN, Delgado AV, Kheirabadi BS, Fedyk CG, Scherer MR, Pusateri AE, . . . Dubick MA (2011) Effect of Hemodilution on Coagulation and Recombinant Factor VIIa Efficacy in Human Blood In Vitro. J Trauma.
http://www.ncbi.nlm.nih.gov/pubmed/21610535
Davidson SJ, Woodhams B (2011) Factor VIIa-Antithrombin complexes during cardiac surgery using cardiopulmonary bypass. Int J Lab Hematol.
http://www.ncbi.nlm.nih.gov/pubmed/21569219
Dutton RP, Parr M, Tortella BJ, Champion HR, Bernard GR, Boffard K, . . . Hauser CJ (2011) Recombinant Activated Factor VII Safety in Trauma Patients: Results From the CONTROL Trial. J Trauma.
http://www.ncbi.nlm.nih.gov/pubmed/21610529
Egorina EM, Sovershaev MA, Hansen JB (2011) The role of tissue factor in systemic inflammatory response syndrome. Blood Coagul Fibrinolysis.
http://www.ncbi.nlm.nih.gov/pubmed/21597365
Figueras J, Monasterio J, Domingo E, Meneses B, Nieto E, Cortadellas J, Garcia-Dorado D (2011) Prothrombotic profile in patients with vasospastic or non vasospastic angina and non significant coronary stenosis. Thromb J 9:10.
http://www.ncbi.nlm.nih.gov/pubmed/21619612
Fu WJ, Zheng L, Wang Q, Deng RT, Ye CQ, Wang SB, . . . Tang HH (2011) [Urinary level of tissue factor and its procoagulant activity in patients with type 2 diabetes.]. Nan Fang Yi Ke Da Xue Xue Bao 31:878-881.
http://www.ncbi.nlm.nih.gov/pubmed/21602148
Guo D, Zhou H, Wu Y, Zhou F, Xu G, Wen H, Zhang X (2011) Involvement of ERK1/2/NF-kappaB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620. Tumour Biol.
http://www.ncbi.nlm.nih.gov/pubmed/21625939
Hengel LG, Versteeg HH (2011) Tissue Factor signaling: a multi-faceted function in biological processes. Front Biosci (Schol Ed) 3:1500-1510.
http://www.ncbi.nlm.nih.gov/pubmed/21622285
Holy EW, Forestier M, Richter EK, Akhmedov A, Leiber F, Camici GG, . . . Tanner FC (2011) Dietary {alpha}-Linolenic Acid Inhibits Arterial Thrombus Formation, Tissue Factor Expression, and Platelet Activation. Arterioscler Thromb Vasc Biol.
http://www.ncbi.nlm.nih.gov/pubmed/21571683
Khan OA, Blann AD, Payne MJ, Middleton MR, Protheroe AS, Talbot DC, . . . Harris AL (2011) Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer. Br J Cancer.
http://www.ncbi.nlm.nih.gov/pubmed/21587257
Knudsen T, Olsen OH, Petersen LC (2011) Tissue factor and factor VIIa cross-species compatibility. Front Biosci 17:3196-3215.
http://www.ncbi.nlm.nih.gov/pubmed/21622229
Lee BJ, Kim JH, Woo SH, Kim DH, Yu YS (2011) Tissue factor is involved in retinoblastoma cell proliferation via both the Akt and extracellular signal-regulated kinase pathways. Oncol Rep.
http://www.ncbi.nlm.nih.gov/pubmed/21617868
Liang HP, Brophy TM, Hogg PJ (2011) Redox properties of the Tissue Factor Cys186-Cys209 disulfide bond. Biochem J.
http://www.ncbi.nlm.nih.gov/pubmed/21595632
Lippi G, Franchini M, Montagnana M, Favaloro EJ (2011) Inherited disorders of blood coagulation. Ann Med.
http://www.ncbi.nlm.nih.gov/pubmed/21585250
Martinet W, Schrijvers DM, De Meyer GR (2011) Necrotic cell death in atherosclerosis. Basic Res Cardiol.
http://www.ncbi.nlm.nih.gov/pubmed/21611880
Mast AE (2011) Alternatively spliced tissue factor pathway inhibitor: Functional Implications. Front Biosci (Schol Ed) 3:1457-1462.
http://www.ncbi.nlm.nih.gov/pubmed/21622281
Mazzolai L, Bouzourene K, Hayoz D, Dignat-George F, Liu JW, Bounameaux H, . . . Kruithof EK (2011) Characterization of Human Late Outgrowth Endothelial Progenitor-Derived Cells under Various Flow Conditions. J Vasc Res 48:443-451.
http://www.ncbi.nlm.nih.gov/pubmed/21625177
McCracken N, Lahu G, Bethke TD (2011) Lack of pharmacokinetic and pharmacodynamic interactions of roflumilast with (R, S)-warfarin in healthy adult subjects. Int J Clin Pharmacol Ther 49:388-396.
http://www.ncbi.nlm.nih.gov/pubmed/21612746
Mobarrez F, He S, Broijersen A, Wiklund B, Antovic A, Antovic J, . . . Wallen H (2011) Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. Thromb Haemost 106.
http://www.ncbi.nlm.nih.gov/pubmed/21614411
Moss J, Rosholm A, Lauren A (2011) Safety and pharmacokinetics of a glycoPEGylated recombinant activated FVII derivative: a randomized first human dose trial in healthy subjects. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21575130
Nakatomi Y, Tsuji M, Nakashima T, Gokudan S, Miyazaki H, Tomokiyo K, . . . Mogi M (2011) Pharmacokinetics, distribution, and excretion of (125)I-labeled human plasma-derived-FVIIa and -FX with MC710 (FVIIa/FX mixture) in rats. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21621824
Pan J, Shi H, Luo X, Ma D, Liang W, Zhang J, . . . Li J (2011) [Construction of replication-deficient recombinant adenovirus vector with hTFPI-2 gene by AdMax system and expression in U937 monocytes in vitro]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 28:326-331.
http://www.ncbi.nlm.nih.gov/pubmed/21604496
Persson E, Olsen OH (2011) Allosteric activation of coagulation factor VIIa. Front Biosci 17:3156-3163.
http://www.ncbi.nlm.nih.gov/pubmed/21622226
Ponschab M, Landoni G, Biondi-Zoccai G, Bignami E, Frati E, Nicolotti D, . . . Zangrillo A (2011) Recombinant Activated Factor VII Increases Stroke in Cardiac Surgery: A Meta-analysis. J Cardiothorac Vasc Anesth.
http://www.ncbi.nlm.nih.gov/pubmed/21596585
Saito Y, Hashimoto Y, Kuroda JI, Yasunaga M, Koga Y, Takahashi A, Matsumura Y (2011) The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation antibody. Eur J Cancer.
http://www.ncbi.nlm.nih.gov/pubmed/21621407
Srinivasan R, Bogdanov VY (2011) Alternatively spliced Tissue Factor: discovery, insights, clinical implications. Front Biosci 17:3061-3071.
http://www.ncbi.nlm.nih.gov/pubmed/21622222
Sugimura H, Tao H, Suzuki M, Mori H, Tsuboi M, Matsuura S, . . . Matsuda T (2011) Genetic susceptibility to lung cancer. Front Biosci (Schol Ed) 3:1463-1477.
http://www.ncbi.nlm.nih.gov/pubmed/21622282
Undas A, Jankowski M, Kaczmarek P, Sladek K, Brummel-Ziedins K (2011) Thrombin generation in chronic obstructive pulmonary disease: Dependence on plasma factor composition. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21624643
Xu C, Gui Q, Chen W, Wu L, Sun W, Zhang N, . . . Fu X (2011) Small interference RNA targeting tissue factor inhibits human lung adenocarcinoma growth in vitro and in vivo. J Exp Clin Cancer Res 30:63.
http://www.ncbi.nlm.nih.gov/pubmed/21619686
Yamamichi S, Fujiwara Y, Kikuchi T, Nishitani M, Matsushita Y, Hasumi K (2011) Extracellular histone induces plasma hyaluronan-binding protein (factor VII activating protease) activation in vivo. Biochem Biophys Res Commun.
http://www.ncbi.nlm.nih.gov/pubmed/21600885
Zhang J, Yang S, Xie Y, Chen X, Zhao Y, He D, Li J (2011) Detection of methylated tissue factor pathway inhibitor 2 and human long DNA in fecal samples of patients with colorectal cancer in China. Cancer Epidemiol.
http://www.ncbi.nlm.nih.gov/pubmed/21621497
__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 17, No. 11 June 1, 2011
(The next issue will be on June 15, 2011)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1VIYzi36diIQjGMaN3yDCRU/
Abe R, Yamashita N, Rochier A, Nixon A, Madri JA, Sumpio BE (2011) Varying Effects of Hemodynamic Forces on Tissue Factor RNA Expression in Human Endothelial Cells. J Surg Res.
http://www.ncbi.nlm.nih.gov/pubmed/21592524
Banfi C, Brioschi M, Lento S, Pirillo A, Galli S, Cosentino S, . . . Mussoni L (2011) Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21605334
Ben-Hadj-Khalifa S, Hezard N, Almawi WY, Remy MG, Florent B, Mahjoub T, Nguyen P (2011) Differential coagulation inhibitory effect of fondaparinux, enoxaparin and unfractionated heparin in cell models of thrombin generation. Blood Coagul Fibrinolysis.
http://www.ncbi.nlm.nih.gov/pubmed/21577096
Butros L, Boayue K, Mathew P (2011) Current difficulties and recent advances in bypass therapy for the management of hemophilia with inhibitors: a new and practical formulation of recombinant factor VIIa. Drug Des Devel Ther 5:275-282.
http://www.ncbi.nlm.nih.gov/pubmed/21625417
Chapman AJ, Blount AL, Davis AT, Hooker RL (2011) Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery. Eur J Cardiothorac Surg.
http://www.ncbi.nlm.nih.gov/pubmed/21601468
Darlington DN, Delgado AV, Kheirabadi BS, Fedyk CG, Scherer MR, Pusateri AE, . . . Dubick MA (2011) Effect of Hemodilution on Coagulation and Recombinant Factor VIIa Efficacy in Human Blood In Vitro. J Trauma.
http://www.ncbi.nlm.nih.gov/pubmed/21610535
Davidson SJ, Woodhams B (2011) Factor VIIa-Antithrombin complexes during cardiac surgery using cardiopulmonary bypass. Int J Lab Hematol.
http://www.ncbi.nlm.nih.gov/pubmed/21569219
Dutton RP, Parr M, Tortella BJ, Champion HR, Bernard GR, Boffard K, . . . Hauser CJ (2011) Recombinant Activated Factor VII Safety in Trauma Patients: Results From the CONTROL Trial. J Trauma.
http://www.ncbi.nlm.nih.gov/pubmed/21610529
Egorina EM, Sovershaev MA, Hansen JB (2011) The role of tissue factor in systemic inflammatory response syndrome. Blood Coagul Fibrinolysis.
http://www.ncbi.nlm.nih.gov/pubmed/21597365
Figueras J, Monasterio J, Domingo E, Meneses B, Nieto E, Cortadellas J, Garcia-Dorado D (2011) Prothrombotic profile in patients with vasospastic or non vasospastic angina and non significant coronary stenosis. Thromb J 9:10.
http://www.ncbi.nlm.nih.gov/pubmed/21619612
Fu WJ, Zheng L, Wang Q, Deng RT, Ye CQ, Wang SB, . . . Tang HH (2011) [Urinary level of tissue factor and its procoagulant activity in patients with type 2 diabetes.]. Nan Fang Yi Ke Da Xue Xue Bao 31:878-881.
http://www.ncbi.nlm.nih.gov/pubmed/21602148
Guo D, Zhou H, Wu Y, Zhou F, Xu G, Wen H, Zhang X (2011) Involvement of ERK1/2/NF-kappaB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620. Tumour Biol.
http://www.ncbi.nlm.nih.gov/pubmed/21625939
Hengel LG, Versteeg HH (2011) Tissue Factor signaling: a multi-faceted function in biological processes. Front Biosci (Schol Ed) 3:1500-1510.
http://www.ncbi.nlm.nih.gov/pubmed/21622285
Holy EW, Forestier M, Richter EK, Akhmedov A, Leiber F, Camici GG, . . . Tanner FC (2011) Dietary {alpha}-Linolenic Acid Inhibits Arterial Thrombus Formation, Tissue Factor Expression, and Platelet Activation. Arterioscler Thromb Vasc Biol.
http://www.ncbi.nlm.nih.gov/pubmed/21571683
Khan OA, Blann AD, Payne MJ, Middleton MR, Protheroe AS, Talbot DC, . . . Harris AL (2011) Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer. Br J Cancer.
http://www.ncbi.nlm.nih.gov/pubmed/21587257
Knudsen T, Olsen OH, Petersen LC (2011) Tissue factor and factor VIIa cross-species compatibility. Front Biosci 17:3196-3215.
http://www.ncbi.nlm.nih.gov/pubmed/21622229
Lee BJ, Kim JH, Woo SH, Kim DH, Yu YS (2011) Tissue factor is involved in retinoblastoma cell proliferation via both the Akt and extracellular signal-regulated kinase pathways. Oncol Rep.
http://www.ncbi.nlm.nih.gov/pubmed/21617868
Liang HP, Brophy TM, Hogg PJ (2011) Redox properties of the Tissue Factor Cys186-Cys209 disulfide bond. Biochem J.
http://www.ncbi.nlm.nih.gov/pubmed/21595632
Lippi G, Franchini M, Montagnana M, Favaloro EJ (2011) Inherited disorders of blood coagulation. Ann Med.
http://www.ncbi.nlm.nih.gov/pubmed/21585250
Martinet W, Schrijvers DM, De Meyer GR (2011) Necrotic cell death in atherosclerosis. Basic Res Cardiol.
http://www.ncbi.nlm.nih.gov/pubmed/21611880
Mast AE (2011) Alternatively spliced tissue factor pathway inhibitor: Functional Implications. Front Biosci (Schol Ed) 3:1457-1462.
http://www.ncbi.nlm.nih.gov/pubmed/21622281
Mazzolai L, Bouzourene K, Hayoz D, Dignat-George F, Liu JW, Bounameaux H, . . . Kruithof EK (2011) Characterization of Human Late Outgrowth Endothelial Progenitor-Derived Cells under Various Flow Conditions. J Vasc Res 48:443-451.
http://www.ncbi.nlm.nih.gov/pubmed/21625177
McCracken N, Lahu G, Bethke TD (2011) Lack of pharmacokinetic and pharmacodynamic interactions of roflumilast with (R, S)-warfarin in healthy adult subjects. Int J Clin Pharmacol Ther 49:388-396.
http://www.ncbi.nlm.nih.gov/pubmed/21612746
Mobarrez F, He S, Broijersen A, Wiklund B, Antovic A, Antovic J, . . . Wallen H (2011) Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. Thromb Haemost 106.
http://www.ncbi.nlm.nih.gov/pubmed/21614411
Moss J, Rosholm A, Lauren A (2011) Safety and pharmacokinetics of a glycoPEGylated recombinant activated FVII derivative: a randomized first human dose trial in healthy subjects. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21575130
Nakatomi Y, Tsuji M, Nakashima T, Gokudan S, Miyazaki H, Tomokiyo K, . . . Mogi M (2011) Pharmacokinetics, distribution, and excretion of (125)I-labeled human plasma-derived-FVIIa and -FX with MC710 (FVIIa/FX mixture) in rats. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21621824
Pan J, Shi H, Luo X, Ma D, Liang W, Zhang J, . . . Li J (2011) [Construction of replication-deficient recombinant adenovirus vector with hTFPI-2 gene by AdMax system and expression in U937 monocytes in vitro]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 28:326-331.
http://www.ncbi.nlm.nih.gov/pubmed/21604496
Persson E, Olsen OH (2011) Allosteric activation of coagulation factor VIIa. Front Biosci 17:3156-3163.
http://www.ncbi.nlm.nih.gov/pubmed/21622226
Ponschab M, Landoni G, Biondi-Zoccai G, Bignami E, Frati E, Nicolotti D, . . . Zangrillo A (2011) Recombinant Activated Factor VII Increases Stroke in Cardiac Surgery: A Meta-analysis. J Cardiothorac Vasc Anesth.
http://www.ncbi.nlm.nih.gov/pubmed/21596585
Saito Y, Hashimoto Y, Kuroda JI, Yasunaga M, Koga Y, Takahashi A, Matsumura Y (2011) The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation antibody. Eur J Cancer.
http://www.ncbi.nlm.nih.gov/pubmed/21621407
Srinivasan R, Bogdanov VY (2011) Alternatively spliced Tissue Factor: discovery, insights, clinical implications. Front Biosci 17:3061-3071.
http://www.ncbi.nlm.nih.gov/pubmed/21622222
Sugimura H, Tao H, Suzuki M, Mori H, Tsuboi M, Matsuura S, . . . Matsuda T (2011) Genetic susceptibility to lung cancer. Front Biosci (Schol Ed) 3:1463-1477.
http://www.ncbi.nlm.nih.gov/pubmed/21622282
Undas A, Jankowski M, Kaczmarek P, Sladek K, Brummel-Ziedins K (2011) Thrombin generation in chronic obstructive pulmonary disease: Dependence on plasma factor composition. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21624643
Xu C, Gui Q, Chen W, Wu L, Sun W, Zhang N, . . . Fu X (2011) Small interference RNA targeting tissue factor inhibits human lung adenocarcinoma growth in vitro and in vivo. J Exp Clin Cancer Res 30:63.
http://www.ncbi.nlm.nih.gov/pubmed/21619686
Yamamichi S, Fujiwara Y, Kikuchi T, Nishitani M, Matsushita Y, Hasumi K (2011) Extracellular histone induces plasma hyaluronan-binding protein (factor VII activating protease) activation in vivo. Biochem Biophys Res Commun.
http://www.ncbi.nlm.nih.gov/pubmed/21600885
Zhang J, Yang S, Xie Y, Chen X, Zhao Y, He D, Li J (2011) Detection of methylated tissue factor pathway inhibitor 2 and human long DNA in fecal samples of patients with colorectal cancer in China. Cancer Epidemiol.
http://www.ncbi.nlm.nih.gov/pubmed/21621497
__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
